453 related articles for article (PubMed ID: 21296484)
1. MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
Catto JW; Alcaraz A; Bjartell AS; De Vere White R; Evans CP; Fussel S; Hamdy FC; Kallioniemi O; Mengual L; Schlomm T; Visakorpi T
Eur Urol; 2011 May; 59(5):671-81. PubMed ID: 21296484
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
3. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?
Schubert M; Junker K; Heinzelmann J
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1673-95. PubMed ID: 26660324
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as regulators of signal transduction in urological tumors.
Fendler A; Stephan C; Yousef GM; Jung K
Clin Chem; 2011 Jul; 57(7):954-68. PubMed ID: 21632885
[TBL] [Abstract][Full Text] [Related]
6. Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.
Aveta A; Cilio S; Contieri R; Spena G; Napolitano L; Manfredi C; Franco A; Crocerossa F; Cerrato C; Ferro M; Del Giudice F; Verze P; Lasorsa F; Salonia A; Nair R; Walz J; Lucarelli G; Pandolfo SD
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446024
[TBL] [Abstract][Full Text] [Related]
7. Functions of circular RNAs in bladder, prostate and renal cell cancer (Review).
Yang L; Zou X; Zou J; Zhang G
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649838
[TBL] [Abstract][Full Text] [Related]
8. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
[TBL] [Abstract][Full Text] [Related]
9. [MicroRNA in prostate cancer].
Nakagawa M
Nihon Rinsho; 2014 Dec; 72(12):2224-8. PubMed ID: 25518362
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
Kumar B; Lupold SE
Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
[TBL] [Abstract][Full Text] [Related]
11. The role of microRNAs in bladder cancer.
Enokida H; Yoshino H; Matsushita R; Nakagawa M
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S60-76. PubMed ID: 27326409
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs play a role in chondrogenesis and osteoarthritis (review).
Wu C; Tian B; Qu X; Liu F; Tang T; Qin A; Zhu Z; Dai K
Int J Mol Med; 2014 Jul; 34(1):13-23. PubMed ID: 24736803
[TBL] [Abstract][Full Text] [Related]
13. Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers.
Polo A; Marchese S; De Petro G; Montella M; Ciliberto G; Budillon A; Costantini S
Sci Rep; 2018 Jul; 8(1):10395. PubMed ID: 29991691
[TBL] [Abstract][Full Text] [Related]
14. Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer.
Coradduzza D; Cruciani S; Arru C; Garroni G; Pashchenko A; Jedea M; Zappavigna S; Caraglia M; Amler E; Carru C; Maioli M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163550
[TBL] [Abstract][Full Text] [Related]
15. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.
Zaravinos A; Radojicic J; Lambrou GI; Volanis D; Delakas D; Stathopoulos EN; Spandidos DA
J Urol; 2012 Aug; 188(2):615-23. PubMed ID: 22704449
[TBL] [Abstract][Full Text] [Related]
16. Next revolution in molecular theranostics: personalized medicine for urologic cancers.
Aoun F; Kourie HR; Artigas C; Roumeguère T
Future Oncol; 2015; 11(15):2205-19. PubMed ID: 26235183
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of microRNAs in bladder cancer.
Yoshino H; Seki N; Itesako T; Chiyomaru T; Nakagawa M; Enokida H
Nat Rev Urol; 2013 Jul; 10(7):396-404. PubMed ID: 23712207
[TBL] [Abstract][Full Text] [Related]
18. Implications of microRNA dysregulation in the development of prostate cancer.
Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
[TBL] [Abstract][Full Text] [Related]
19. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
Sharma N; Baruah MM
Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
[TBL] [Abstract][Full Text] [Related]
20. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
